Egypt strengthens medical partnerships to localize vaccine manufacturing in Africa
The Egyptian Drug Authority (EDA) participated in the fifth edition of the Africa Health ExCon 2026, which aims to enhance health cooperation among African nations. This participation comes within the framework of Egypt's efforts to develop the health sector and support innovation in the pharmaceutical industry.
Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority, witnessed the signing ceremony of several important strategic partnerships during the conference. These agreements primarily aim to localize vaccine manufacturing within Egypt and the African continent, in addition to transferring modern technology to ensure the availability of high-quality medicines and vaccines.
This step is part of Egypt's strategy to enhance regional health security, as the Authority seeks to reduce reliance on importing vaccines from abroad. Through these partnerships, Egypt hopes to become a regional hub for vaccine manufacturing, which will contribute to meeting the needs of Egyptian citizens and our brothers in Africa.
This international cooperation underscores Egypt's leading role on the continent, especially in light of global health challenges that require concerted efforts. The Drug Authority continues to work on attracting foreign investment and developing human capital to ensure the sustainability of these vital medical projects.
In conclusion, these partnerships represent a positive step toward achieving self-sufficiency in the field of vaccines. It is expected that these efforts will reflect on improving the level of healthcare in Egypt and providing innovative medical solutions that meet global standards in the near future.